Background: Percutaneous vertebroplasty is a minimally invasive technique used for treatment of painful vertebral compression fracture.
Introduction
SPINAL metastases account for 5% of all cancer patients, patients with breast, lung and prostate account for more than 50% of spinal metastases patients, site of metastasis is 60-80% in the thoracic spine, 15-30% in lumbar spine and 10 in cervical spine [4] .
About 89% of spinal metastases are considered of the extradural type, and about 80% of them occur in the posterior element of the veretebra leading to pain and spinal instability [18] .
The main objective for these patients is palliative treatment, the most common presentation is Correspondence to: Dr. Ahmed A. Abdelkhalek, The Department of Neurosurgery, Faculty of Medicine, Cairo University severe back pain, several modalities were used to alleviate the pain either through medication radiotherapy or surgery. Medications as anti-inflam matory drugs and opioids are used but may be inadequately relieving pain that require bed rest which my increase the risk of pneumonia, deep vein thrombosis and pulmonary embolism [20] , Radiotherapy is often the main line of treatment in patients who cannot tolerate surgery, with radiosensitive tumors, or those who have poor prognosis but relieve of pain may take up to two weeks after radiotherapy [19] .
Surgery are used for decompression of the spinal cord and in spinal instability, but it is highly invasive with major complications so it is not suitable in spinal metastases patients due to short life expectancy, that is why we used percutaneous vertebroblasty as it is minimally invasive, with use of local anesthesia, less blood loss and less tissue trauma leading to lower morbidity and mortality when compared with open surgery and leading to rapid and efficient pain reduction together with spinal stability [21] .
In percutaneous veretebroplasy, pain relief occur due to increase spinal stability, tumor necrosis and tissue necrosis due to the use of polymethyl methacrylate (PMMA) polymerization as it has local cytotoxic and antitumor effect [19] .
Aim of study:
To evaluate the rule of vertebroplasty in treatment of spinal metastasis of thoracolumbar region regarding pain relief.
Patients and Methods
This is a retrospective study of 14 cases of metastatic spinal disease of thoracolumbar region operated upon by percutaneous vertebroplasty between February 2012 to April 2015 at Cairo University Hospital.
The procedure was selected for patients with painful vertebral compression fracture affecting 2153 2154 Percutaneous Vertebroplasty in Metastatic Thoracolumbar Spine Disease Regarding Pain Relief patient daily activities, in patient who had failed medical treatment.
The patients were 8 females and 6 males, with age 35 to 71 years (average 53 years).
The primary tumors were breast cancer in 6 patients (43%), lung cancer in 5 patients (36%) and prostate cancer in 3 patients (21%), 6 patients of our study (43%) were in the thoracic spine and 8 patients (57%) were in the lumbar spine.
Inclusion criteria:
• Painful vertebral compression fractures that affecting the patient daily activities. • Intractable pain not responding to medical treatment. All patients with back pain as a main complaint with duration ranging from 28 to 150 days.
Full history taking, general and neurological examination was don for all patients and informed consent was taken.
The pain intensity was recorded by visual analog scale (VAS) was recorded both before, following the procedure, and six months after the procedure, VAS ranging from 0 (no pain) to 10 (worst pain ever).
All patients had preoperative laboratory investigations as complete blood picture, prothrombin time and concentration.
Pre-operative Plain X-ray and MRI of the spine were obtained in all patients as well as serial postoperative X-ray one and six months after the procedure.
Of the 14 patients 11 patients had one level injection and 3 had two level injections
All patients were treated by Vertebroplasty using the percutaneous unilateral (12 vertebra) or bilateral portal (5 vertebra) under local infiltration.
Postoperatively All patients had a spinal support for three days with early ambulation next day after the procedure, all patients were discharged the next day after procedure.
Before discharge all patients had chest X-ray, neurological examination with evaluation of pain with visual analogue scale.
Complications as pneumothorax, rib fracture and cement leakage were monitored.
Follow-up at 1,3 and 6 months to asses pain using VAS and X-rays were done to assess the effect of cement on adjacent vertebral levels.
Surgical technique of percutaneous vertebroplaty:
The patient is positioned prone, using fluoroscopy initial images are acquired to confirm the targeted level a prophylactic dose of broad spectrum antibiotic is given before the procedure, Local anesthesia is then infiltrated into skin, subcutaneous tissues and periosteum, following this an 11or 13 gauge needle is passed along the anaesthetized tract to penetrate the cortex of veretebra using a transpedicular approach, further images are needed to guide needle placement into anterior quadrant of the targeted vertebral body, ideally as close to midline, bone biopsies can be taken if required, cement is instilled under close imaging until anterior two thirds of the veretebral body is filled and cement is equally distributed on both sides, patients require bed rest for 2 hours under vital and neurological monitoring patients can be mobilized and discharged on the same day.
Results
In our study 14 cases of metastatic spinal disease of thoracolumbar region operated upon by percutaneous vertebroplasty.
The age of our patients ranging from 35 to 71 years with a mean age of 53 years.
In our study there were 8 females (57%) and 6 males (43%), 6 patients of our study (43%) were in the thoracic spine and 8 patients (57%) were in the lumbar spine.
Back pain was the main symptom in all cases (100%) with duration ranging from 28 to 150 days. Intensity of pain using visual analogue scale (VAS) was recorded preoperatively and the mean VAS was 7.3 (range 6 to 10).
The primary tumors were breast cancer in 6 patients (43%), lung cancer in 5 patients (3 6%) and prostate cancer in 3 patients (21%). The mean operative duration in this study was 57.5 minutes, with a minimum of 25 minutes and a maximum of 90 minutes.
• The average time for a single level was 28min. • The average time for a double level was 38min.
Of the 14 patients 11 patients (79%) had one level injection and 3 patients (21%) had two level injection, unilateral injections were done in 12 vertebrae (71%), and bilateral injections in 5 vertebrae (29%). 13 patients (92.8%) of our study showed significant pain improvement within 48 hours of the procedure, at 6 months follow-up 12 patients (85.7%) had persistent pain relief. Transient radiculopathy occurred in 1 patient due to cement leakage into the neural foramen which resolved after one week.
The mean VAS preoperative was 7.3 (range 6 to 10), decreasing to 2.8 after the procedure and to 1.5 at the last follow-up visit. No general complications were found, cement leakage were found in 8 patients (57%), the leak was noticed in intervertebral disc, needle track or neural foramen.
Postoperative complications in the form of nerve root radiculopathy due to cement leakage in one patient (7%) which resolved after one week by medical treatment (steroids).
Case 1:
Male patient 57 years with primary adenocarcinoma of the lung with vertebral metastasis L2,3, can't move because of severe back pain, after procedure pain markedly improved. 
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Discussion
Patients with severe back pain due to spinal metastasis can be treated by radiotherapy but its effect as pain relieve may be delayed for up to two weeks or not effective, open surgery can't be done due poor general condition or short life expectancy of patients with metastasis, in our study we used percutaneous vertebroplasty as a minimally invasive procedure alternative to radiotherapy and surgery in reducing pain in those patients [9] . 6 patients of our study (43%) were in the thoracic spine and 8 patients (57%) were in the lumbar spine, also the lumbar spine was the most common site in 6 patients (75%) as reported by Alvarez et al., [1] .
During the procedure we used the fluoroscopic guidance both anteroposterior and lateral view to better asses needle progression and cement injection, Cotton et al., [7] also used the fluoroscopy, Barr et al., [2] & Gangi et al., [13] used a combination of CT and fluoroscopy, David et al., [8] , Jensen et al., 1997 recommend the use of venogram to prevent cement leak in the vena cava Unilateral injections were done in 12 vertebrae (71%), and bilateral injections in 5 vertebrae (29%), bilateral injections may be better than unilateral but unilateral injection allow filling of both halves of vertebral body with less operative time.
In our patients the average amount of cement injected was 3ml, Cotten et al., [6] . In addition, Belkoff et al., [3] . have used 2-4ml of cement, Gangi et al., [13] have used 1.5ml of cement.
The rate of vertebroplasty related complications reported in metastatic disease is 10% which is higher than when used in osteoporotic patients 2-5% due to poor general condition and vertebral body destruction in metastatic patients.
In our study cement leakage occurred in 8 patients (57%) most frequently venous leakage followed by along the needle track, the higher incidence of leakage due to anatomy disruption by tumor extension, Cotten et al., 1998 has 72% leakage with paravertebral leakage as the most frequent type followed by epidural leakage, Weill et al., [17] reported 38% leakage.
One patient of our study (7%) had nerve root compression radiculopathy due to cement leakage and resolved after one week by medical treatment (steroids), Cotten et al., [7] , found nerve root compression that required surgery in two of eight foraminal leakages and transient femoral neurop-athy in one of 21 paravertebral leakages. Depriester et al., [9] found nerve root compression that required surgery in 1.5% of injections, with radicular symptoms in up to 8%. So if leakage noticed during injection it is important to stop PMMA injection and plane another injection strategy.
Relieve of pain in percutaneous vertebroplasty occur due to increased spine stability, sensory nerve ending destruction and tumor necrosis, tissue destruction occur due to local cytotoxic effect of PMMA, reduction of pain with spinal stability lead to increased activity and better quality of life [21] . 13 patients (92.8%) of our study showed significant pain improvement within 48 hours of the procedure, at 6 months follow-up 12 patients (85.7%) had persistent pain relief. Transient radiculopathy occurred in 1 patient due to cement leakage into the neural foramen which resolved after one month.
In our study VAS had reduced from 7.3 preoperatively to 2.8 after the procedure and to 1.5 at the last follow-up visit.
Gangi et al., [13] has 60-85% significant pain reliever, Deramond et al reported 80% pain improvement in 101 patients with metastatic spinal disease.
Cortet et al., [5] reported 97% pain reduction within 48 hours, 89% at three months and 75% after 6 months.
Kaemmerlen et al., [14] had used vertebroplasty as an adjuvant to radiotherapy, pain relieve occurred in 85% in less than 48 hours. Calmels et al., [12] reported 92% pain relieve in 6 months follow-up period in his study of 52 patients and Cotten et al., reported 75% pain relief in his study.
In all studies there were 73 to 100% pain relief at 6 months follow-up [1,10,12,14,15] , so the result of our study as 85.7% pain relief at 6 months follow-up in is matching with the other studies, the short follow-up period (six months) is due to the short life expectancy of the metastatic patients.
Conclusion:
Percutaneous vertebroplasty is a minimally invasive procedure that is effective, safe and rapid in reducing pain in patients with metastatic spinal disease of thoracolumbar spine, so it should be considered the first choice in treating pain in those patients.
